Mucommune
Richard Cone is an Academy Professor of Biophysics at Johns Hopkins University. A former Professor in Biophysics and Biology at Johns Hopkins University. He retired in 2017 to focus full-time on advancing Mucommune. Over 25 years of experience advancing products for female reproductive health, bringing products into multiple Phase 3 clinical trials for contraception and HIV.
This person is not in any offices
Mucommune
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform developed at Johns Hopkins University and University of North Carolina at Chapel Hill.